Phase IIIb Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.

Trial Profile

Phase IIIb Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Methadone (Primary)
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Acronyms EQUIMETH2
  • Most Recent Events

    • 15 Feb 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01793480).
    • 15 Feb 2013 Planned end date changed from 2 Nov 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
    • 13 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top